Pharmaceutical Technology - May 2020

Learn how companies are leveraging BCS-based biowaivers in place of bioequivalence studies to overcome current challenges in drug development. HOW ARE YOU PROGRESSING DRUG DEVELOPMENT DURING THE PANDEMIC? More informa� on at absorp� on.com/bcs For quotes, email contact@absorp� on.com ©2020 Absorp on Systems, LP. All rights reserved.

• PT0520_eBook
• PTebook0520_001_Cover
• PTebook0520_002_TOCMasthead_MR
• PTebook0520_004-009_DataQuality_Challener
• PTebook0520_010-014_ProcessSimulation_Agalloco
• PTebook0520_016-019_SingleUse_Emerson
• PTebook0520_020-023_PreFilled Syringes_Thomas
• PTebook0520_024-029_SeparationViralvector_Millipore
• PTebook0520_030-033_ContaminationCellTherapy_Mirasol
• PTebook0520_034-037_ContaminationUpstream_Thermo
• PTebook0520_038-042_ContaminationControl_SKAN
• Absorption Systems - Ad
• Emergent - Ad
• Gemu - Ad
• Mission Pharmacal - IO
• Pfanstiehl - Ad
• Tergus - Ad
• Veltek - Ad